Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

[Image: see text] We report the development and characterization of compound 22 (MK-5046), a potent, selective small molecule agonist of BRS-3 (bombesin receptor subtype-3). In pharmacological testing using diet-induced obese mice, compound 22 caused mechanism-based, dose-dependent reductions in foo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sebhat, Iyassu K., Franklin, Christopher, Lo, Michael M.-C., Chen, David, Jewell, James P., Miller, Randy, Pang, Jianmei, Palyha, Oksana, Kan, Yanqing, Kelly, Theresa M., Guan, Xiao-Ming, Marsh, Donald J., Kosinski, Jennifer A., Metzger, Joseph M., Lyons, Kathryn, Dragovic, Jasminka, Guzzo, Peter R., Henderson, Alan J., Reitman, Marc L., Nargund, Ravi P., Wyvratt, Matthew J., Lin, Linus S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2010
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018145/
https://ncbi.nlm.nih.gov/pubmed/24900253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml100196d
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados